Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lowell S Young

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Antimicrobial Agents and Chemotherapy|September 10, 2009
Reconsidering some approved antimicrobial agents for tuberculosisLowell S Young
Surgical Technology International|June 6, 2017
Antibiotic Update for the SurgeonLowell S Young
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 1997
Therapy of sepsisLowell S. Young
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Hematologic effects of linezolid versus vancomycinLowell S Young
Antimicrobial Agents and Chemotherapy|November 25, 2004
A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formationGeorge Carter, Lowell S Young, Luiz E Bermudez
Microbial Drug Resistance (Larchmont, N.Y.)|April 6, 2006
In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacteriumLia Danelishvili, Lowell S Young, Luiz E Bermudez
Antimicrobial Agents and Chemotherapy|August 30, 2005
Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteriaLia Danelishvili, Martin Wu, Lowell S Young, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2003
Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in miceLuiz E Bermudez, Robert Reynolds, Peter Kolonoski, et al.
The Journal of Infectious Diseases|June 7, 2003
Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium diseaseLuiz E Bermudez, Peter Kolonoski, Mary Petrofsky, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex diseaseLuiz E Bermudez, Peter Kolonoski, Lianne E Seitz, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Antimicrobial Agents and Chemotherapy|September 10, 2009
Reconsidering some approved antimicrobial agents for tuberculosisLowell S Young
Surgical Technology International|June 6, 2017
Antibiotic Update for the SurgeonLowell S Young
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 1, 1997
Therapy of sepsisLowell S. Young
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 20, 2004
Hematologic effects of linezolid versus vancomycinLowell S Young
Antimicrobial Agents and Chemotherapy|November 25, 2004
A subinhibitory concentration of clarithromycin inhibits Mycobacterium avium biofilm formationGeorge Carter, Lowell S Young, Luiz E Bermudez
Microbial Drug Resistance (Larchmont, N.Y.)|April 6, 2006
In vivo efficacy of phage therapy for Mycobacterium avium infection as delivered by a nonvirulent mycobacteriumLia Danelishvili, Lowell S Young, Luiz E Bermudez
Antimicrobial Agents and Chemotherapy|August 30, 2005
Genomic approach to identifying the putative target of and mechanisms of resistance to mefloquine in mycobacteriaLia Danelishvili, Martin Wu, Lowell S Young, et al.
Antimicrobial Agents and Chemotherapy|July 25, 2003
Thiosemicarbazole (thiacetazone-like) compound with activity against Mycobacterium avium in miceLuiz E Bermudez, Robert Reynolds, Peter Kolonoski, et al.
The Journal of Infectious Diseases|June 7, 2003
Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium diseaseLuiz E Bermudez, Peter Kolonoski, Mary Petrofsky, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2004
SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex diseaseLuiz E Bermudez, Peter Kolonoski, Lianne E Seitz, et al.
Pageof 2